|
The African Seed Trade
Association (AFSTA) recognizes the importance of modern biotechnology
as an efficient tool in enhancing food production and agricultural development
in Africa, in combination with other existing and new technologies. Agriculture
will remain a key area in uplifting the socio-economic conditions in view
of its average contribution of 70% to national economies.
Modern biotechnology
has made possible significant crop improvements such as pest and disease
resistant varieties and improved quality food and development of a number
of new varieties widely grown in both developed and developing countries.
Africa loses an estimated 40% of its grain crops due to pest, disease
and weed damage in the field and post harvest losses. It clearly stands
to benefit from adoption of new unique traits, which have already proved
their worth in 52 million ha globally.
By means of Modern
Biotechnology, Africa will be able to develop superior varieties that
can perform well under the severe biotic and abiotic stresses that are
extremely detrimental to the African agriculture and at the same time
produce better quality food and feed. Indeed, the African continent has
real need to increase food production efficiency per hectare for its fast
growing population, thereby also contributing to reducing deforestation
and environmental degradation. Therefore,
·
AFSTA encourages and supports research and applications of agricultural
biotechnology to improve agricultural productivity.
· AFSTA urges all African stakeholders, both public and private,
to actively participate in worldwide debates on the safe use of agricultural
biotechnology.
· AFSTA affirms that appropriate policies and programs must be
developed to foster rapid developments in agricultural biotechnology in
order to ensure a safe and sufficient supply of food, which will ultimately
raise African farmers' standard of living.
· AFSTA recommends that adequate regulations and proper scientific
protocols must be established as a priority to assess on scientific basis
and allowing for African level and existing conditions, possible health
and other environmental risks to ensure Safe Modern Biotechnology in Africa.
However AFSTA considers that there are no specific risks inherent to modern
biotechnology and that the safety assessment has to be made on a product-by-product
basis. A prerequisite is to enact biosafety regulatory systems required
under the Cartagena Biosafety Protocol in such a manner that these systems
are practical, enforceable and affordable.
· Considering the economic situation in Africa in general and the
level of materials and equipment required to properly conduct modern biotechnology,
African countries need help to build capacity for developing and assessing
the safety of new transgenic crops. AFSTA appeals to both multilateral
development organizations and foreign aid donors to assist in strengthening
African countries in several aspects such as education of the stakeholders
regarding opportunities, as well as the possible associated risks, suitable
regulatory protocols, promotion of entrepreneurship and local private
sector participation, research infrastructure, special program for tropical
plants, etc. It is especially urgent to build capacity within national
regulatory authorities so as to ensure adequate regulatory oversight.
· AFSTA is willing to cooperate with international organizations
dealing with agricultural biotechnology and participate in any debates
by providing the practical expertise of its members on the subject.
|
|